Cheryl McAlpine
Impact in
- Ophthalmology top 5%
- Ocular Oncology and Treatments
-
- Immunotherapy and Immune Responses
Papers in
- Oncology 8
- CAR-T cell therapy research 8
-
- Immunotherapy and Immune Responses 8
- Co-authors
- Mario Sznol (3 shared papers)Jeffrey R. Infante (3 shared papers)Omid Hamid (3 shared papers)Neil Steven (3 shared papers)Mark R. Middleton (3 shared papers)Alexander N. Shoushtari (3 shared papers)T.R. Jeffry Evans (1 shared paper)Revashnee Naidoo (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Investigative Ophthalmology & Visual Science (1 paper)Clinical Cancer Research (1 paper)Cancer Research (1 paper)Journal of Neurology Neurosurgery & Psychiatry (1 paper)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Cheryl McAlpine
12 papers receiving 262 citations
Peers
Comparison fields: 5 of 36
- Ophthalmology 118
- Immunology 134
- Oncology 138
- Radiology, Nuclear Medicine and Imaging 60
- Molecular Biology 68
Countries citing papers authored by Cheryl McAlpine
This map shows the geographic impact of Cheryl McAlpine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl McAlpine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl McAlpine more than expected).
Fields of papers citing papers by Cheryl McAlpine
This network shows the impact of papers produced by Cheryl McAlpine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl McAlpine. The network helps show where Cheryl McAlpine may publish in the future.
Co-authors
The 25 scholars most cited alongside Cheryl McAlpine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 182 | |
| 2 | 2016 | 39 | |
| 3 | 2017 | 18 | |
| 4 | G-protein-coupled receptor heterodimerization: assay technologies to clinical significance. | 2007 | 14 |
| 5 | 2023 | 8 | |
| 6 | Safety, efficacy and biology of the gp100 TCR-based bispecific T cell redirector IMCgp100 in advanced uveal melanoma | 2017 | 6 |
| 7 | 2021 | 3 | |
| 8 | 1976 | 3 | |
| 9 | 2022 | 2 | |
| 10 | 2021 | 2 | |
| 11 | 2023 | 1 | |
| 12 | 2019 | 1 |
About Cheryl McAlpine
Cheryl McAlpine is a scholar working on Oncology, Immunology, Radiology, Nuclear Medicine and Imaging, Biotechnology and Molecular Biology, having authored 12 papers that have together received 279 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), CAR-T cell therapy research (8 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Cancer Research and Treatments (3 papers), Ocular Oncology and Treatments (2 papers), Steroid Chemistry and Biochemistry (1 paper), Click Chemistry and Applications (1 paper) and Traumatic Brain Injury and Neurovascular Disturbances (1 paper). The work is most often cited by research in Ophthalmology (118 citations), Immunology (134 citations), Oncology (138 citations), Radiology, Nuclear Medicine and Imaging (60 citations) and Molecular Biology (68 citations). Cheryl McAlpine has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Mario Sznol, Jeffrey R. Infante, Omid Hamid, Neil Steven, Mark R. Middleton, Alexander N. Shoushtari, T.R. Jeffry Evans, Revashnee Naidoo, Jacob Hurst and Sion Lewis. Their work appears in journals such as Journal of Clinical Oncology, Investigative Ophthalmology & Visual Science, Clinical Cancer Research, Cancer Research and Journal of Neurology Neurosurgery & Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.